TEANECK, N.J., Oct. 16, 2024 /CNW/ -- Cognizant (NASDAQ:CTSH) today announced significant enhancements to its Cognizant Neuro ® AI platform, aimed at enabling enterprises to rapidly discover, ...
The 5th HIV Research for Prevention Conference (HIVR4P 2024) held in Lima, Peru, marked a significant milestone in the global ...
Hillyer, MD, President and CEO of NYBCe, and General Partner and Manager of NYBC Ventures. “With a $50 million commitment, we’ve deployed capital across 15 companies that are delivering breakthrough ...
The biotechnology industry is rapidly evolving, with innovative companies pushing the boundaries of science and medicine. To ...
Zacks.com on MSN14h
Gilead Sciences (GILD) Rises As Market Takes a Dip: Key FactsGilead Sciences (GILD) ended the recent trading session at $85.83, demonstrating a +0.91% swing from the preceding day's closing price. This move outpaced the S&P 500's daily loss of 0.76%. Meanwhile, ...
Wells Fargo analyst Mohit Bansal has maintained their bullish stance on ABBV stock, giving a Buy rating on October 11. Mohit Bansal has given ...
This model has become known as the Triple Helix Model, as it combines three key stakeholders woven together to create the ‘DNA’ of scientific innovation and are key to innovation in a knowledge-based ...
The global cell therapy manufacturing market is poised for remarkable growth, with an expected valuation of USD 4,134.48 ...
The pharma will work with Triana Biomedicines on molecular glue degraders. Elsewhere, Akeso raised $250 million and a MASH drug developer got a well-known board chair.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback